2017 - Transplantation Science Symposium


This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.

Tolerance

10.46 - Recognition of Intact Donor Class I by Recipient CD8+ T Cells is Required for Tolerance Induction Following Liver-Directed Transgene Expression

Presenter: Mario, Leong, Sydney, Australia
Authors:

RECOGNITION OF INTACT DONOR CLASS I BY RECIPIENT CD8+ T CELLS IS REQUIRED FOR TOLERANCE INDUCTION FOLLOWING LIVER-DIRECTED TRANSGENE EXPRESSION

Mario Leong 0; Alexandra Sharland 0; Moumita Paul-Heng 0; Eithne Cunningham 0; Daniel Bunker 0; Kate Bremner 0; Zane Wang 0; Chuanmin Wang 0; Szun Szun Tay 0; Claire McGuffog 0; Grant Logan 0; Ian Alexander 0; Min Hu 0; Stephen Alexander 0; Tim Sparwasser 0; Patrick Bertolino 0; David Bowen 0,0; Alex Bishop 0

2Sydney Medical School, The University of Sydney, Sydney, Germany; 3Gene Therapy Group, Children's Medical Research Institute, Sydney, Germany; 4Liver Immunobiology Group, Centenary Institute, Sydney, Germany; 5Twincore Instititute for Infection Immunology, Hannover Medical School, Hannover, Germany

Introduction: AAV-mediated expression of donor MHC I (H-2K? or H-2K?) in recipient liver induces donor-specific tolerance in a mouse skin transplant model where Kb or Kd are mismatched between donor and host [1]. Recognition of both intact and processed allogeneic class I could contribute to tolerance induction.

Aims and Methods: To determine the relative importance of intact and processed class I in tolerance induction, we generated rAAV-K?-D227K and K?-D227K vectors where a point mutation in the class I alpha 3 domain abrogates CD8 binding [2] and direct allorecognition but does not interfere with recognition of processed peptides. Expression of WT or mutant class I on hepatocytes was assessed by FACS and IHC. TCR-transgenic T cells recognizing intact (Des-RAG) or processed (TCR75) allogeneic class I were used as reporter cells in adoptive transfer experiments. Skin bearing the mismatched MHC I was grafted onto uninjected recipients or mice inoculated with rAAV encoding WT or D227K mutant Kb or Kd. In some recipients, Tregs were depleted using anti-FR4 or Diphtheria toxin (DT). Interferon gamma production by responding T cells was determined using ELISpot.

Results: WT and D227K class I were expressed on hepatocytes at comparable levels. Adoptive transfer assays confirmed that the D227K mutation abrogated recognition of intact Kb by CD8+ Des-RAG T cells, whilst recognition of processed Kd peptides by TCR75-RAG cells was unimpaired. Uninjected B10.BR mice rejected Kb-mismatched 178.3 skin (MST=16 d), while grafts onto rAAV-K?-injected mice survived indefinitely (p<0.001). rAAV-K?-D227K only slightly prolonged graft survival (MST=27d, p<0.05). These results were recapitulated in the B6.Kd to C57BL/6 model. The modest survival prolongation of skin grafts in mice inoculated with K?-D227K was abrogated when the recipients were treated with anti-FR4 (clone TH6) to deplete Tregs. Similarly, the survival prolongation of Kd-mismatched B6.Kd grafts onto DEREG recipients treated with rAAV-Kd-D227K (MST=28d compared with 20d in mice receiving DT alone) was blocked when mice receiving Kd-D227K were also treated with DT (MST 18 days, p=0.0046). Treg depletion did not shorten survival of skin grafts in mice inoculated with WT MHC class I vectors. Interferon-gamma production by unfractionated or CD8-enriched splenocytes from primed C57BL/6 mice in response to B6.Kd stimulators was over fourfold lower in mice inoculated with WT Kd than in those receiving Kd-D227K (p=0.038).

Conclusions: Recognition of intact MHC class I by alloreactive CD8+ T cells is required for tolerance induction via liver-directed expression of donor MHC class I. Indirect recognition of class I allopeptides and generation of Tregs can produce a modest prolongation of class I-mismatched skin graft survival but does not induce tolerance.
{{AbstractFigure.1}}{{AbstractFigure.2}}


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada